| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = -$74,037 ) |
| | 2026 | 2024 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01TR003844 | Informing Ethical Translation of Xenotransplantation Clinical Trials | 000 | 4 | NIH | 12/12/2025 | -$74,037 |
|
| Issue Date FY: 2025 ( Subtotal = $471,003 ) |
| | 2025 | 2025 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01HG013153 | From Research to Clinic: Addressing Ethical and Policy Challenges Facing the Gene Therapy Ecosystem | 000 | 2 | NIH | 6/30/2025 | $471,003 |
|
| Issue Date FY: 2024 ( Subtotal = $1,023,506 ) |
| | 2024 | 2024 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01HG013153 | From Research to Clinic: Addressing Ethical and Policy Challenges Facing the Gene Therapy Ecosystem | 000 | 1 | NIH | 8/1/2024 | $574,582 |
| | 2024 | 2024 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01TR003844 | Informing Ethical Translation of Xenotransplantation Clinical Trials | 000 | 4 | NIH | 8/8/2024 | $458,233 |
| | 2024 | 2024 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01HG013153 | From Research to Clinic: Addressing Ethical and Policy Challenges Facing the Gene Therapy Ecosystem | 001 | 1 | NIH | 9/26/2024 | $0 |
| | 2024 | 2020 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG010531 | Understanding All of Us Enrollees and Decliners  Motivations to Enhance Recruitment and Retention: FQHC's barriers to caring for patients with clinically actionable genetic research results | 000 | 2 | NIH | 2/6/2024 | -$5,074 |
| | 2024 | 2020 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG010531 | Understanding All of Us Enrollees and Decliners  Motivations to Enhance Recruitment and Retention: FQHC's barriers to caring for patients with clinically actionable genetic research results | 001 | 2 | NIH | 2/6/2024 | -$4,235 |
|
| Issue Date FY: 2023 ( Subtotal = $173,409 ) |
| | 2023 | 2023 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01TR003844 | Informing Ethical Translation of Xenotransplantation Clinical Trials | 000 | 3 | NIH | 7/28/2023 | $468,182 |
| | 2023 | 2021 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG011277 | Creating an initial ethics framework for biomedical data modeling by mapping and exploring key decision points | 000 | 2 | NIH | 1/9/2023 | -$202,624 |
| | 2023 | 2021 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG011277 | Creating an initial ethics framework for biomedical data modeling by mapping and exploring key decision points | 002 | 2 | NIH | 1/12/2023 | -$1 |
| | 2023 | 2020 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG011277 | Creating an initial ethics framework for biomedical data modeling by mapping and exploring key decision points | 001 | 1 | NIH | 1/12/2023 | -$37,898 |
| | 2023 | 2020 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG011277 | Creating an initial ethics framework for biomedical data modeling by mapping and exploring key decision points | 001 | 1 | NIH | 1/12/2023 | -$54,251 |
| | 2023 | 2020 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01HG010168 | Actionable Ethics Oversight for Human-Animal Chimera Research | 000 | 3 | NIH | 12/28/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $467,833 ) |
| | 2022 | 2022 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01TR003844 | Informing Ethical Translation of Xenotransplantation Clinical Trials | 001 | 2 | NIH | 8/16/2022 | $0 |
| | 2022 | 2022 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01TR003844 | Informing Ethical Translation of Xenotransplantation Clinical Trials | 000 | 2 | NIH | 7/30/2022 | $467,833 |
| | 2022 | 2020 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG010531 | Understanding All of Us Enrollees and Decliners  Motivations to Enhance Recruitment and Retention: FQHC's barriers to caring for patients with clinically actionable genetic research results | 001 | 2 | NIH | 7/22/2022 | $0 |
| | 2022 | 2020 | HASTINGS CENTER INC | 21 MALCOLM GORDON RD | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG010531 | Understanding All of Us Enrollees and Decliners  Motivations to Enhance Recruitment and Retention: FQHC's barriers to caring for patients with clinically actionable genetic research results | 000 | 2 | NIH | 7/22/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $703,469 ) |
| | 2021 | 2021 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01TR003844 | Informing Ethical Translation of Xenotransplantation Clinical Trials | 000 | 1 | NIH | 8/9/2021 | $500,844 |
| | 2021 | 2021 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG011277 | Creating an initial ethics framework for biomedical data modeling by mapping and exploring key decision points | 000 | 2 | NIH | 8/11/2021 | $202,625 |
|
| Issue Date FY: 2020 ( Subtotal = $1,108,109 ) |
| | 2020 | 2020 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG011277 | Creating an initial ethics framework for biomedical data modeling by mapping and exploring key decision points | 000 | 1 | NIH | 8/31/2020 | $143,150 |
| | 2020 | 2020 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG010531 | Understanding All of Us Enrollees and Decliners  Motivations to Enhance Recruitment and Retention: FQHC's barriers to caring for patients with clinically actionable genetic research results | 001 | 2 | NIH | 7/27/2020 | $189,814 |
| | 2020 | 2020 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG010531 | Understanding All of Us Enrollees and Decliners  Motivations to Enhance Recruitment and Retention: FQHC's barriers to caring for patients with clinically actionable genetic research results | 002 | 2 | NIH | 8/3/2020 | $158,409 |
| | 2020 | 2020 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01HG010168 | Actionable Ethics Oversight for Human-Animal Chimera Research | 000 | 3 | NIH | 6/30/2020 | $516,736 |
| | 2020 | 2020 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG011277 | Creating an initial ethics framework for biomedical data modeling by mapping and exploring key decision points | 000 | 1 | NIH | 8/31/2020 | $100,000 |
| | 2020 | 2019 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG010531 | Understanding All of Us Enrollees and Decliners  Motivations to Enhance Recruitment and Retention: FQHC's barriers to caring for patients with clinically actionable genetic research results | 000 | 1 | NIH | 3/6/2020 | $0 |
| | 2020 | 2019 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG010531 | Understanding All of Us Enrollees and Decliners  Motivations to Enhance Recruitment and Retention: FQHC's barriers to caring for patients with clinically actionable genetic research results | 000 | 1 | NIH | 3/6/2020 | $0 |
| | 2020 | 2017 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01HG008805 | Goals and Practices for Next Generation Prenatal Testing | 000 | 3 | NIH | 11/21/2019 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $754,995 ) |
| | 2019 | 2019 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG010531 | Understanding All of Us Enrollees and Decliners  Motivations to Enhance Recruitment and Retention: FQHC's barriers to caring for patients with clinically actionable genetic research results | 000 | 1 | NIH | 7/31/2019 | $227,089 |
| | 2019 | 2019 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG010531 | Understanding All of Us Enrollees and Decliners  Motivations to Enhance Recruitment and Retention: FQHC's barriers to caring for patients with clinically actionable genetic research results | 001 | 1 | NIH | 8/21/2019 | $39,500 |
| | 2019 | 2019 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01HG010168 | Actionable Ethics Oversight for Human-Animal Chimera Research | 001 | 2 | NIH | 6/19/2019 | $527,906 |
| | 2019 | 2019 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R21HG010531 | Understanding All of Us Enrollees and Decliners  Motivations to Enhance Recruitment and Retention: FQHC's barriers to caring for patients with clinically actionable genetic research results | 001 | 1 | NIH | 8/21/2019 | -$39,500 |
| | 2019 | 2018 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01HG010168 | Actionable Ethics Oversight for Human-Animal Chimera Research | 000 | 1 | NIH | 11/5/2018 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $432,737 ) |
| | 2018 | 2018 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01HG010168 | Actionable Ethics Oversight for Human-Animal Chimera Research | 000 | 1 | NIH | 9/12/2018 | $432,737 |
|
| Issue Date FY: 2017 ( Subtotal = $379,382 ) |
| | 2017 | 2017 | HASTINGS CENTER INC, THE | 21 MALCOLM GORDON DR | GARRISON | NY | 10524-4125 | PUTNAM | USA | R01HG008805 | Goals and Practices for Next Generation Prenatal Testing | 000 | 3 | NIH | 6/1/2017 | $379,382 |
|
| Issue Date FY: 2016 ( Subtotal = $378,764 ) |
| | 2016 | 2016 | HASTINGS CENTER (THE) | ROUTE 9D | GARRISON | NY | 10524 | PUTNAM | USA | R01HG008805 | Goals and Practices for Next Generation Prenatal Testing | 000 | 2 | NIH | 5/20/2016 | $378,764 |
|
| Issue Date FY: 2015 ( Subtotal = $400,399 ) |
| | 2015 | 2015 | HASTINGS CENTER (THE) | ROUTE 9D | GARRISON | NY | 10524 | PUTNAM | USA | R01HG008805 | Goals and Practices for Next Generation Prenatal Testing | 000 | 1 | NIH | 8/10/2015 | $400,399 |
|
| Issue Date FY: 2008 ( Subtotal = $170,009 ) |
| | 2008 | 2008 | HASTINGS CENTER (THE) | ROUTE 9D | GARRISON | NY | 10524 | PUTNAM | USA | U13MH078722 | PHARMACOLOGICALLY TREATING BEHAVIORAL DISTURBANCES IN CHILDREN: ENGAGING THE CONT | 000 | 3 | NIH | 7/1/2008 | $170,009 |
|
|
